Drug delivery, formulation

125 Results

Sofgen Pharmaceuticals obtains Drug Establishment License

Sofgen Pharmaceuticals | 23-Jan-2023 | Press Release

Health Canada certifies Sofgen Pharmaceuticals in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at...

Tackling Early Phase Development with First-In-Human Study Solutions

Altasciences | 25-Oct-2022 | Technical / White Paper

Bringing new drugs to market, from lead candidate selection through preclinical testing, to clinical proof of concept, is a complex, time-consuming, and...

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 13-Jul-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Formulation Effects on Tablet Surface Properties and Film Coating Adhesion

JRS PHARMA | 01-Jul-2022 | Technical / White Paper

The aim of this study was to investigate the influence of different commonly applied lubricants and disintegrants on tablet surface and film coating adhesion....

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Nanomilling for Better Solubility and Bioavailability

Altasciences | 07-Apr-2022 | Technical / White Paper

40% of marketed drugs and 90% of active pharmaceutical ingredients (APIs) are poorly water-soluble. Nanomilling is a proven technique that can overcome...

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

How Formulation Development Affects Manufacturing

Catalent | 24-Feb-2022 | Insight Guide

Due to advances in technology and increased development of parenteral drugs, one of the fastest-growing choices for drug delivery in the pharmaceutical...

Funtrition by Procaps expands its gummy offerings with new Gummy manufacturing facility in the US

Softigel by Procaps | 14-Feb-2022 | Press Release

New Funtrition Gummy Manufacturing Facility in Florida Slated to be Fully Operational by Q1 2023, to Support Increased U.S. and global Demand of Advanced...

Spray Dried Powders for High Dose Drug Delivery

Catalent Pharma Solutions | 01-Feb-2022 | Product Presentation

This Catalent webinar will explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung...

Maximizing Drug Formulation for First-In-Human Trials

Altasciences | 13-Dec-2021 | Case Study

The manufacture of a drug product for clinical trials is of critical importance. The formulation, manufacturing, and assessment of a drug candidate during...

The Future of Innovation In Pharmaceutical Delivery Systems

Softigel by Procaps | 06-Dec-2021 | Product Presentation

More than 4 decades of expertise in innovative technologies and value-added pharmaceutical solutions. Procaps Group's purpose is to spread its legacy...

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Flexibility and capability in pre-filled syringes

Curia | 15-Nov-2021 | Technical / White Paper

Pre-filled syringes have risen in popularity in recent years but the pandemic’s impact on drug development, manufacturing and patient care has created...

Overcoming Solubility Challenges with Liquid-Filled Capsules

Altasciences | 28-Sep-2021 | Technical / White Paper

Poorly soluble molecules comprise more than 70% of the small molecule products entering the drug development pipeline today, and are difficult to formulate...

A Better Approach, for Better Pain Trials

Signant Health | 27-Sep-2021 | Technical / White Paper

Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often...

Bioavailability Enhancement Techniques to Improve Patients' Lives

Piramal Pharma Solutions | 16-Sep-2021 | Technical / White Paper

Oral bioavailability is a constant challenge for developers of new chemical entities. Low solubility and permeability often reduce the fraction of an orally...

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Formulation and development strategies for amorphous solid dispersions

Lonza | 17-Sep-2020 | Sponsored Link

A large and increasing fraction of orally administered small molecules in pharma company pipelines have poor oral absorption due to low aqueous solubility...

Accelerated development of first-in-human programs. Lonza’s SimpliFiH® Solutions

Lonza | 25-Aug-2020 | Sponsored Link

The presented program is laid out as integrated Drug Substance, Particle Engineering and Drug Product services, enabling drug substance and drug product...

Flow Cytometry Services

Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Frontage Laboratories | 01-Dec-2019 | Technical / White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...

Assessing Pre-Existing Antibodies in Biotheraputic Development

Frontage Laboratories | 21-Aug-2019 | Technical / White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

BBK Worldwide | 24-Jul-2019 | Technical / White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

Marken Delivers Compassionate Use Dose of Emergency Medication to Critical Pediatric Patient

Marken | 26-Jun-2018 | Case Study

A desperate mother in Germany urged her team of doctors to reach out to a Marken client on behalf of her two year old girl. The child was battling leukemia...

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

The Power to Make, A Virtual Tour

Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

B. Braun OEM. Tailor-made solutions for the healthcare industry

B. Braun Melsungen AG | 10-May-2016 | Technical / White Paper

B. Braun OEM offers standard products or customized versions. Even the standard range contains hundreds of product versions, with which countless applications...

UPLC Analysis of Methoxy & 2-Hydroxypropoxy in Hypromellose

SGS Life Science Services | 25-Apr-2016 | Technical / White Paper

Because of its use in the pharmaceutical and food industries, the USP has established standards relating to the amount of methoxyl and 2-hydroxypropoxyl...

Data Mining At The FDA

Oracle Health Sciences | 20-Apr-2016 | Technical / White Paper

The FDA has recommended the use of data mining to the drug industry, and their new Data Mining at FDA white paper summarizes their past and current data...

Looking for a prefilled option for your sensitive compound?

Vetter Pharma International GmbH | 12-Apr-2016 | Product Brochure

With more sophisticated therapies coming to market, manufacturers need more options for complex, sensitive molecules. Vetter-Ject® is a patented, ready-to-use...

A Technical Insight – Extractables and Leachables Studies

RSSL | 25-Jan-2016

Contaminants leaching from pharmaceutical container systems and product packaging has increased the awareness of the health risks posed by extractables...

World Courier tackles the last mile challenge

World Courier | 18-Jan-2016 | Research Study

The global pharmaceutical industry will have spent more than $10 billion on cold chain logistics in 2015, getting products and clinical trial supplies...

A Structured Approach to Enhancing Bioavailability for Early Development Phase Molecules

Catalent Pharma Solutions | 11-Jan-2016 | Insight Guide

Drug development cost, lengthier development cycles, and identifying a suitable delivery platform were identified as the top three business challenges...

An integrated solution to deliver a complex pharmaceutical assignment.

Recipharm AB | 28-Sep-2015 | Product Brochure

Developing andmanufacturing breakthrough pharmaceuticals for a global market is always a challenge. At Recipharm, we’ve developed world-class solutions...

Next-Generation Orphan Drug Delivery Ebook

Catalent Pharma Solutions | 31-Aug-2015 | Technical / White Paper

According to the National Organization for Rare Disorders (NORD), a disease is rare if it affects fewer than 200,000 Americans. Big Pharma used to ignore...

Article on Viral Clearance for Biopharmaceuticals

Catalent Pharma Solutions | 31-Aug-2015 | Technical / White Paper

Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals. These studies are a key component...

Solvent Considerations in Solid Dosage Manufacturing

Norwich Pharmaceuticals Inc | 15-Jun-2015 | Technical / White Paper

As the pharmaceutical industry moves to more potent APIs and complex delivery systems, the need to work with solvents is increasing. This white paper discusses...

Seeking Drug Approval via the 505(b)(2) NDA Option

QPS | 07-May-2015 | Technical / White Paper

Today, many pharmaceutical companies are choosing the 505(b)(2) New Drug Approval (NDA) regulatory pathway. The 505(b)(2) NDA route relies on investigations...

Optimize Your Sponsor-CRO Relationship

SGS Life Science Services | 20-Apr-2015 | Technical / White Paper

Within the pharmaceutical industry, there are six dominant methods used to model outsourcing strategy. This white paper details how a hybrid strategy can...

How Sponsors and CROs Benefit From EDC Efficiencies

Merge eClinical | 01-Apr-2015 | Technical / White Paper

Intense competition in the prescription drug market is driving pharmaceutical companies to expedite their drug discovery and development processes. Pharmaceutical...

Outsourcing-Pharma

Resources